Infectious Disease Advisor news story
Among individuals with HIV receiving COVID-19 vaccines, breakthrough COVID-19 infection does not appear to significantly affect CD4+ counts, according to study results published in Open Forum Infectious Diseases.
Recent studies have found that individuals with HIV are at higher risk for breakthrough COVID-19 infection. However, few studies have investigated the effect of breakthrough COVID-19 infection on CD4+ counts.
To bridge this knowledge gap, investigators from Johns Hopkins University School of Public Health conducted a secondary analysis sourcing data from the Corona-Infectious-Virus Epidemiology Team (CIVETs-II) from the North American AIDS Cohort Collaboration on Research and Design (NA-ACCORD). Vaccinated individuals with HIV with a breakthrough COVID-19 infection between 2020 and 2022 were evaluated for immediate and short-term CD4+ counts, defined as 0 to 60 and 61 to 180 days, respectively.
Read the full news story here.
/Infectious Disease Advisor requires free registration if more than 5 articles are viewed per month/
Source : Infectious Disease Advisor
Related HIV and Co-Infections News
Get involved
Are you living with HIV/AIDS? Are you part of a community affected by HIV/AIDS and co-infections? Do you work or volunteer in the field? Are you motivated by our cause and interested to support our work?
Subscribe
Stay in the loop and get all the important EATG updates in your inbox with the EATG newsletter. The HIV & co-infections bulletin is your source of handpicked news from the field arriving regularly to your inbox.